Clear cell carcinoma of the kidney is a form of cancer that affects the linings of small tubules in the kidney. These tubules are where wastes are filtered and removed and where urine is formed. Recent medical studies have indicated a growing number of cases of this type of cancer, especially among Americans and Europeans. This condition, which is now considered the most common type of kidney cancer, results in various symptoms including gross haematuria, anaemia, loss of weight, pain in the flank region, and anorexia.
Clear cell carcinoma of the kidney is managed with surgery, in which the cancer cells are excised or removed, along with a margin of healthy tissues around them. This surgical procedure can be very expensive in Western countries but very affordable in Southeast Asia. World-class hospitals in Singapore, which are staffed by internationally trained and certified oncologists and nephrologists, charge only a fraction of the cost charged by doctors in the United States and the United Kingdom. However, they feature the same sophisticated facilities, advanced technology, and innovative equipment found in Western countries.
The same quality of oncology care is also available at other medical hubs in the region, like Thailand and Malaysia, where foreign patients can also find numerous hospitals accredited by the Joint Commission International (JCI) and a long list of highly qualified surgeons. By going to these countries, international patients can also access high-quality after-surgery treatment that includes chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Most internationally-accredited medical institutions also offer comprehensive services that include travel arrangement, accommodation, and transportation to make medical travel convenient for patients and their families. Patients seeking treatment in Southeast Asia may also qualify for several clinical trials for novel cancer treatments that may deliver improved patient outcomes.